Genes of human longevity: An endless quest?

Miriam Capri, Aurelia Santoro, Paolo Garagnani, Maria Giulia Bacalini, Chiara Pirazzini, Fabiola Olivieri, Antonio Procopio, Stefano Salvioli, Claudio Franceschi

Research output: Contribution to journalArticle

Abstract

Human longevity is a complex trait in which genetics, epigenetics, environmental and stochasticity differently contribute. To disentangle the complexity, our studies on genetics of longevity were, at the beginning, mainly focused on the extreme phenotypes, i.e. centenarians who escaped the major age-related diseases compared with cross sectional cohorts. Recently, we implemented this model by studying centenarians’ offspring and offspring of non-long lived parents. In association, during studies on many candidate genes SNPs, positively or negatively correlated with longevity have been identified. The results obtained on Insulin-like Growth Factor 1 Receptor (IGF1R) polymorphisms showed a correlation between specific genetic variants combinations and the low plasma level of IGF1 in centenarians, suggesting an impact of the IGF-I/insulin pathway on human longevity. This pathway together with mammalian target of rapamycin (mTOR) will be reviewed as being the most promising for longevity. Further, we will summarise the role of apolipoprotein E (APOE) variants in human longevity since the results of the large European project GEHA (Genetics of Healthy Aging) indicate APOE among the chromosomal loci associated with longevity. On the other hand, the identification of longevity-related genes does not explain the mechanisms of healthy aging and longevity rather pose questions on epigenetic contribution, gene regulation and the interactions with essential genomes, i.e. mitochondrial DNA and microbiota. To fully disentangle what appears to be an endless quest, all the components of the complexity of human longevity genetics are taken into account.

Original languageEnglish
Pages (from-to)707-717
Number of pages11
JournalCurrent Vascular Pharmacology
Volume12
Issue number5
Publication statusPublished - 2014

Fingerprint

Genes
Apolipoproteins E
Epigenomics
Somatomedin Receptors
Microbiota
Medical Genetics
Sirolimus
Insulin-Like Growth Factor I
Mitochondrial DNA
Single Nucleotide Polymorphism
Parents
Genome
Insulin
Phenotype

Keywords

  • APOE
  • ELOVL2
  • Epigenetics
  • IGF-1
  • Longevity
  • Microbiota
  • mtDNA
  • mTOR

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology
  • Medicine(all)

Cite this

Capri, M., Santoro, A., Garagnani, P., Bacalini, M. G., Pirazzini, C., Olivieri, F., ... Franceschi, C. (2014). Genes of human longevity: An endless quest? Current Vascular Pharmacology, 12(5), 707-717.

Genes of human longevity : An endless quest? / Capri, Miriam; Santoro, Aurelia; Garagnani, Paolo; Bacalini, Maria Giulia; Pirazzini, Chiara; Olivieri, Fabiola; Procopio, Antonio; Salvioli, Stefano; Franceschi, Claudio.

In: Current Vascular Pharmacology, Vol. 12, No. 5, 2014, p. 707-717.

Research output: Contribution to journalArticle

Capri, M, Santoro, A, Garagnani, P, Bacalini, MG, Pirazzini, C, Olivieri, F, Procopio, A, Salvioli, S & Franceschi, C 2014, 'Genes of human longevity: An endless quest?', Current Vascular Pharmacology, vol. 12, no. 5, pp. 707-717.
Capri M, Santoro A, Garagnani P, Bacalini MG, Pirazzini C, Olivieri F et al. Genes of human longevity: An endless quest? Current Vascular Pharmacology. 2014;12(5):707-717.
Capri, Miriam ; Santoro, Aurelia ; Garagnani, Paolo ; Bacalini, Maria Giulia ; Pirazzini, Chiara ; Olivieri, Fabiola ; Procopio, Antonio ; Salvioli, Stefano ; Franceschi, Claudio. / Genes of human longevity : An endless quest?. In: Current Vascular Pharmacology. 2014 ; Vol. 12, No. 5. pp. 707-717.
@article{596f58236d0849189a57aed772f9731d,
title = "Genes of human longevity: An endless quest?",
abstract = "Human longevity is a complex trait in which genetics, epigenetics, environmental and stochasticity differently contribute. To disentangle the complexity, our studies on genetics of longevity were, at the beginning, mainly focused on the extreme phenotypes, i.e. centenarians who escaped the major age-related diseases compared with cross sectional cohorts. Recently, we implemented this model by studying centenarians’ offspring and offspring of non-long lived parents. In association, during studies on many candidate genes SNPs, positively or negatively correlated with longevity have been identified. The results obtained on Insulin-like Growth Factor 1 Receptor (IGF1R) polymorphisms showed a correlation between specific genetic variants combinations and the low plasma level of IGF1 in centenarians, suggesting an impact of the IGF-I/insulin pathway on human longevity. This pathway together with mammalian target of rapamycin (mTOR) will be reviewed as being the most promising for longevity. Further, we will summarise the role of apolipoprotein E (APOE) variants in human longevity since the results of the large European project GEHA (Genetics of Healthy Aging) indicate APOE among the chromosomal loci associated with longevity. On the other hand, the identification of longevity-related genes does not explain the mechanisms of healthy aging and longevity rather pose questions on epigenetic contribution, gene regulation and the interactions with essential genomes, i.e. mitochondrial DNA and microbiota. To fully disentangle what appears to be an endless quest, all the components of the complexity of human longevity genetics are taken into account.",
keywords = "APOE, ELOVL2, Epigenetics, IGF-1, Longevity, Microbiota, mtDNA, mTOR",
author = "Miriam Capri and Aurelia Santoro and Paolo Garagnani and Bacalini, {Maria Giulia} and Chiara Pirazzini and Fabiola Olivieri and Antonio Procopio and Stefano Salvioli and Claudio Franceschi",
year = "2014",
language = "English",
volume = "12",
pages = "707--717",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Genes of human longevity

T2 - An endless quest?

AU - Capri, Miriam

AU - Santoro, Aurelia

AU - Garagnani, Paolo

AU - Bacalini, Maria Giulia

AU - Pirazzini, Chiara

AU - Olivieri, Fabiola

AU - Procopio, Antonio

AU - Salvioli, Stefano

AU - Franceschi, Claudio

PY - 2014

Y1 - 2014

N2 - Human longevity is a complex trait in which genetics, epigenetics, environmental and stochasticity differently contribute. To disentangle the complexity, our studies on genetics of longevity were, at the beginning, mainly focused on the extreme phenotypes, i.e. centenarians who escaped the major age-related diseases compared with cross sectional cohorts. Recently, we implemented this model by studying centenarians’ offspring and offspring of non-long lived parents. In association, during studies on many candidate genes SNPs, positively or negatively correlated with longevity have been identified. The results obtained on Insulin-like Growth Factor 1 Receptor (IGF1R) polymorphisms showed a correlation between specific genetic variants combinations and the low plasma level of IGF1 in centenarians, suggesting an impact of the IGF-I/insulin pathway on human longevity. This pathway together with mammalian target of rapamycin (mTOR) will be reviewed as being the most promising for longevity. Further, we will summarise the role of apolipoprotein E (APOE) variants in human longevity since the results of the large European project GEHA (Genetics of Healthy Aging) indicate APOE among the chromosomal loci associated with longevity. On the other hand, the identification of longevity-related genes does not explain the mechanisms of healthy aging and longevity rather pose questions on epigenetic contribution, gene regulation and the interactions with essential genomes, i.e. mitochondrial DNA and microbiota. To fully disentangle what appears to be an endless quest, all the components of the complexity of human longevity genetics are taken into account.

AB - Human longevity is a complex trait in which genetics, epigenetics, environmental and stochasticity differently contribute. To disentangle the complexity, our studies on genetics of longevity were, at the beginning, mainly focused on the extreme phenotypes, i.e. centenarians who escaped the major age-related diseases compared with cross sectional cohorts. Recently, we implemented this model by studying centenarians’ offspring and offspring of non-long lived parents. In association, during studies on many candidate genes SNPs, positively or negatively correlated with longevity have been identified. The results obtained on Insulin-like Growth Factor 1 Receptor (IGF1R) polymorphisms showed a correlation between specific genetic variants combinations and the low plasma level of IGF1 in centenarians, suggesting an impact of the IGF-I/insulin pathway on human longevity. This pathway together with mammalian target of rapamycin (mTOR) will be reviewed as being the most promising for longevity. Further, we will summarise the role of apolipoprotein E (APOE) variants in human longevity since the results of the large European project GEHA (Genetics of Healthy Aging) indicate APOE among the chromosomal loci associated with longevity. On the other hand, the identification of longevity-related genes does not explain the mechanisms of healthy aging and longevity rather pose questions on epigenetic contribution, gene regulation and the interactions with essential genomes, i.e. mitochondrial DNA and microbiota. To fully disentangle what appears to be an endless quest, all the components of the complexity of human longevity genetics are taken into account.

KW - APOE

KW - ELOVL2

KW - Epigenetics

KW - IGF-1

KW - Longevity

KW - Microbiota

KW - mtDNA

KW - mTOR

UR - http://www.scopus.com/inward/record.url?scp=84924091788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924091788&partnerID=8YFLogxK

M3 - Article

C2 - 24350927

AN - SCOPUS:84924091788

VL - 12

SP - 707

EP - 717

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 5

ER -